A study for effectiveness and safety of tocilizumab therapy in rheumatoid arthritis patients with renal insufficiency.
Phase of Trial: Phase IV
Latest Information Update: 01 Oct 2015
Price : $35 *
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms ACTRA-RI
- 05 Jan 2015 Status changed from active, no longer recruiting to completed as reported in the results published in the Annals of the Rheumatic Diseases.
- 27 Aug 2014 New trial record